Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA sequence recognition by bispyrazinonaphthalimides antitumor agents.

Carolina Carrasco1, Alexandra Joubert, Christelle Tardy

  • 1INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, 59045 Lille, France.

Biochemistry
|October 8, 2003
PubMed
Summary

This study explores new anticancer drugs, pyrazinonaphthalimide derivatives, that bind selectively to G.C-rich DNA sequences. Dimer forms show higher affinity and stability, with linker modifications impacting DNA binding effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antifungal products and associated mechanisms of action in the fight against Didymella segeticola responsible for tea and tobacco leaf spot diseases.

Pesticide biochemistry and physiology·2026
Same author

Chlorophenylpyrazolone derivatives as novel PD-L1-targeted inhibitors of the PD-1/PD-L1 immune checkpoint.

Bioorganic & medicinal chemistry letters·2026
Same author

The known and unknown of wuyiencin: a potent natural product active against phytopathogenic fungi.

Biochemical pharmacology·2026
Same author

Experimental and MEDT Study of Sydnone-Alkyne Cycloaddition-Based Synthesis of 1,4-Disubstituted Pyrazoles and In Silico Investigation of Their Binding to HCV and HIV Proteins.

Molecules (Basel, Switzerland)·2026
Same author

The Chemistry and Pharmacology of the Alkaloid Barettin and Its Analogues from the Marine Sponge <i>Geodia barretti</i>: Progress and Perspectives.

Marine drugs·2026
Same author

RPA directly stimulates Mer3 helicase processivity to ensure normal crossover formation in meiosis.

Nature communications·2026

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Bifunctional DNA intercalating agents are promising anticancer agents.
  • Elinafide, a dimeric naphthalimide, serves as a lead compound for DNA bisintercalation.
  • Optimizing DNA sequence recognition is key to enhancing drug efficacy.

Purpose of the Study:

  • To investigate the DNA sequence preference of novel tetracyclic pyrazinonaphthalimide derivatives.
  • To evaluate the impact of dimerization and linker modifications on drug-DNA interactions.
  • To elucidate the binding mechanism and sequence selectivity of these potential anticancer agents.

Main Methods:

  • Synthesis of monomeric and dimeric pyrazinonaphthalimide analogues.
  • Melting temperature measurements and Surface Plasmon Resonance (SPR) for DNA binding affinity.

Related Experiment Videos

  • DNase I footprinting for sequence selectivity analysis.
  • SPR footprinting with modified oligonucleotides to probe DNA groove accessibility.

    • Main Results:

    • Dimerization significantly enhances drug affinity for DNA and promotes selective interaction with G.C sites.
    • The specific aminoalkyl linker stabilizes drug-DNA complexes; methylation reduces affinity and increases dissociation rates.
    • Drugs exhibit high preference for G.C-rich sequences and are sensitive to modifications in the DNA minor groove.

    Conclusions:

    • Tetracyclic pyrazinonaphthalimide dimers are potent DNA-binding agents with high G.C sequence selectivity.
    • The linker's structure critically influences binding affinity and complex stability.
    • SPR footprinting is a robust method for characterizing DNA-binding small molecules' sequence selectivity.